Benchmarking the scientific output of the Innovative Medicines Initiative

Rebalancing innovation, affordability, and access for orphan drugs in the European Union.

The Lancet regional health. Europe·2026

Early access disparities in innovative therapies across the US, EU, China, and Japan.

Frontiers in medicine·2025

COVID-19 burden of illness in people who are immunocompromised due to cancer: an expert opinion review.

The oncologist·2025

Is COVID-19 Still a Threat? An Expert Opinion Review on the Continued Healthcare Burden in Immunocompromised Individuals.

Advances in therapy·2024

Developing Therapies for C3 Glomerulopathy: Report of the Kidney Health Initiative C3 Glomerulopathy Trial Endpoints Work Group.

Clinical journal of the American Society of Nephrology : CJASN·2024

Evaluation of antibody-based single cell type imaging techniques coupled to multiplexed imaging of N-glycans and collagen peptides by matrix-assisted laser desorption/ionization mass spectrometry imaging.

Analytical and bioanalytical chemistry·2023

An engineered nanopore identifies saccharides, amino acids, peptides and ribonucleotides.

Nature biotechnology·2026

Integration of proteomic aging clocks in a phase 2a clinical trial supports simultaneous geroprotective assessment.

Nature biotechnology·2026

Engineered genomic attachment sites for site-specific recombinases enable high-efficiency integration in plants and human cells.

Nature biotechnology·2026

AI-enhanced adaptive virtual screening of large libraries for ligand discovery.

Nature biotechnology·2026

A Scientometric Mapping of Global Lenacapavir and HIV Research: Dynamism, Visualization, and Emerging Patterns.

International journal of preventive medicine·2026

Nanotheragnosis: an emerging frontier review in personalized cancer medicine.

Therapeutic delivery·2026

Growth Outcomes and Safety of Recombinant Growth Hormone in Noonan Syndrome: A Systematic Review and Meta-Analysis.

Indian journal of endocrinology and metabolism·2026

Pharmacodynamics of Free VEGF After Treatment with the Port Delivery Platform with Ranibizumab in Patients with Neovascular Age-Related Macular Degeneration.

Ophthalmology science·2026

When lesion-directed therapy is not enough: blue rubber bleb nevus syndrome in a young adult-a case report.

Frontiers in pediatrics·2026

COVID-19 mRNA Vaccines as Antigen-Agnostic Immunomodulators: A Repurposing Perspective.

Medical sciences (Basel, Switzerland)·2026

Related Experiment Videos

Benchmarking the scientific output of the Innovative Medicines Initiative

Related Concept Videos

Rebalancing innovation, affordability, and access for orphan drugs in the European Union.

Early access disparities in innovative therapies across the US, EU, China, and Japan.

COVID-19 burden of illness in people who are immunocompromised due to cancer: an expert opinion review.

Is COVID-19 Still a Threat? An Expert Opinion Review on the Continued Healthcare Burden in Immunocompromised Individuals.

Developing Therapies for C3 Glomerulopathy: Report of the Kidney Health Initiative C3 Glomerulopathy Trial Endpoints Work Group.

Evaluation of antibody-based single cell type imaging techniques coupled to multiplexed imaging of N-glycans and collagen peptides by matrix-assisted laser desorption/ionization mass spectrometry imaging.

An engineered nanopore identifies saccharides, amino acids, peptides and ribonucleotides.

Integration of proteomic aging clocks in a phase 2a clinical trial supports simultaneous geroprotective assessment.

Engineered genomic attachment sites for site-specific recombinases enable high-efficiency integration in plants and human cells.

AI-enhanced adaptive virtual screening of large libraries for ligand discovery.

A Scientometric Mapping of Global Lenacapavir and HIV Research: Dynamism, Visualization, and Emerging Patterns.

Nanotheragnosis: an emerging frontier review in personalized cancer medicine.

Growth Outcomes and Safety of Recombinant Growth Hormone in Noonan Syndrome: A Systematic Review and Meta-Analysis.

Pharmacodynamics of Free VEGF After Treatment with the Port Delivery Platform with Ranibizumab in Patients with Neovascular Age-Related Macular Degeneration.

When lesion-directed therapy is not enough: blue rubber bleb nevus syndrome in a young adult-a case report.

COVID-19 mRNA Vaccines as Antigen-Agnostic Immunomodulators: A Repurposing Perspective.

Related Experiment Videos

Benchmarking the scientific output of the Innovative Medicines Initiative

Related Concept Videos

Related Articles